Skip to content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:
Get the latest shareable resources on coping with COVID-19 from NIMH:

Principal Investigator

Photo of Karen Berman

Karen Faith Berman, M.D.

Section on Integrative Neuroimaging
Section on Psychosis and Cognitive Studies
Clinical and Translational Neuroscience Branch


Dr. Berman is a Senior Investigator and Chief of the Section on Integrative Neuroimaging and the Clinical Brain Disorders Branch at the National Institutes of Health, NIMH Intramural Research Program.  After receiving her M.D. degree at St. Louis University, she completed a medical internship at Washington University in St. Louis and had residency training in psychiatry at the University of California at San Diego. Dr. Berman also completed residency training in nuclear medicine at the NIH Warren G. Magnusen Clinical Center and is board certified in both psychiatry and nuclear medicine. She has received a number of awards, including the A.E. Bennett Award for Neuropsychiatric Research of the Society of Biological Psychiatry, the National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award, the NIH Bench to Bedside Award, and the NIH Director’s Award for her outstanding pioneering research on Williams Syndrome. Dr. Berman’s research group conducts translational investigations, using multimodal neuroimaging to bridge the gap between neurogenetic, molecular, cellular, and system-level mechanisms of brain dysfunction and the cognitive and behavioral manifestations of neurosychiatric disorders neurodevelopmental and genetic sources such as schizophrenia and Williams syndrome, as well of other conditions impacting cognition such as normal aging. They also study the effects of gonadal steroid hormones on brain function.  This body of work has been published in Nature Neuroscience, Neuron, the Journal of Clinical Investigation, the Proceedings of the National Academy of Sciences, and the Journal of Neuroscience, among others.

Research Interests

Dr. Berman’s group uses functional neuroimaging to map brain activity and neurochemical mechanisms associated with normal higher cognitive function as well as dysfunction in neuropsychiatric illnesses such as schizophrenia, illnesses having genetic sources of cognitive dysfunction such as Williams syndrome and other conditions impacting cognition such as normal aging. They also study the effects of gonadal steroid hormones on brain function.

Selected Publications

Jabbi M, Kippenhan JS, Kohn P, Marenco S, Mervis CB, Morris CA, Meyer-Lindenberg A, Berman KF (2012). The Williams syndrome chromosome 7q11.23 hemideletion confers hypersocial, anxious personality coupled with altered insula structure and function. Proc Natl Acad Sci U S A 109, E860-6. [Pubmed Link]

Gregory MD, Kippenhan JS, Eisenberg DP, Kohn PD, Dickinson D, Mattay VS, Chen Q, Weinberger DR, Saad ZS, Berman KF (2017). Neanderthal-Derived Genetic Variation Shapes Modern Human Cranium and Brain. Sci Rep 7, 6308. [Pubmed Link]

Meyer-Lindenberg A, Hariri AR, Munoz KE, Mervis CB, Mattay VS, Morris CA, Berman KF (2005). Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci 8, 991-3. [Pubmed Link]

Marenco S, Meyer C, Kuo S, van der Veen JW, Shen J, DeJong K, Barnett AS, Apud JA, Dickinson D, Weinberger DR, Berman KF (2016). Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings. Am J Psychiatry 173, 527-34. [Pubmed Link]

Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF (2002). Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5, 267-71. [Pubmed Link]

Magnuson Clinical Center, Room 3C103A, MSC 1365

Phone: +1 301 496 7603
Fax: +1 301 480 7795